[(2R)-3-(3-bromo-4-hydroxyphenyl)-1-[4-(3-hydroxypiperidin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate

C34H44BrN5O6 — CID 143294653

IUPAC[(2R)-3-(3-bromo-4-hydroxyphenyl)-1-[4-(3-hydroxypiperidin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate
SMILESO=C(O[C@H](Cc1ccc(O)c(Br)c1)C(=O)N1CCC(N2CCCC(O)C2)CC1)N1CCC(N2CCc3ccccc3NC2=O)CC1
InChIInChI=1S/C34H44BrN5O6/c35-28-20-23(7-8-30(28)42)21-31(32(43)37-15-10-25(11-16-37)39-14-3-5-27(41)22-39)46-34(45)38-17-12-26(13-18-38)40-19-9-24-4-1-2-6-29(24)36-33(40)44/h1-2,4,6-8,20,25-27,31,41-42H,3,5,9-19,21-22H2,(H,36,44)/t27?,31-/m1/s1
InChIKeyLPQYABDKXLYRQM-SLJLDQLWSA-N
MW698.66 g/mol
LogP4.20
Rot. Bonds6

About [(2R)-3-(3-bromo-4-hydroxyphenyl)-1-[4-(3-hydroxypiperidin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate

[(2R)-3-(3-bromo-4-hydroxyphenyl)-1-[4-(3-hydroxypiperidin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate (PubChem CID 143294653) has the molecular formula C34H44BrN5O6 and a molecular weight of 698.66 g/mol. Its IUPAC name is [(2R)-3-(3-bromo-4-hydroxyphenyl)-1-[4-(3-hydroxypiperidin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate.

Molecular Properties

Compound Name[(2R)-3-(3-bromo-4-hydroxyphenyl)-1-[4-(3-hydroxypiperidin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate
PubChem CID143294653
Molecular FormulaC34H44BrN5O6
Molecular Weight698.66 g/mol
Exact Mass697.25
IUPAC Name[(2R)-3-(3-bromo-4-hydroxyphenyl)-1-[4-(3-hydroxypiperidin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate
SMILESO=C(O[C@H](Cc1ccc(O)c(Br)c1)C(=O)N1CCC(N2CCCC(O)C2)CC1)N1CCC(N2CCc3ccccc3NC2=O)CC1
InChIInChI=1S/C34H44BrN5O6/c35-28-20-23(7-8-30(28)42)21-31(32(43)37-15-10-25(11-16-37)39-14-3-5-27(41)22-39)46-34(45)38-17-12-26(13-18-38)40-19-9-24-4-1-2-6-29(24)36-33(40)44/h1-2,4,6-8,20,25-27,31,41-42H,3,5,9-19,21-22H2,(H,36,44)/t27?,31-/m1/s1
InChIKeyLPQYABDKXLYRQM-SLJLDQLWSA-N
XLogP4.20
TPSA125.89 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms46
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500698.66
LogP ≤ 54.20
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Analyze [(2R)-3-(3-bromo-4-hydroxyphenyl)-1-[4-(3-hydroxypiperidin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R)-3-(3-bromo-4-hydroxyphenyl)-1-[4-(3-hydroxypiperidin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate?
The IUPAC name of [(2R)-3-(3-bromo-4-hydroxyphenyl)-1-[4-(3-hydroxypiperidin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate (CID 143294653) is [(2R)-3-(3-bromo-4-hydroxyphenyl)-1-[4-(3-hydroxypiperidin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate.
What is the SMILES notation for [(2R)-3-(3-bromo-4-hydroxyphenyl)-1-[4-(3-hydroxypiperidin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate?
The canonical SMILES for [(2R)-3-(3-bromo-4-hydroxyphenyl)-1-[4-(3-hydroxypiperidin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate is O=C(O[C@H](Cc1ccc(O)c(Br)c1)C(=O)N1CCC(N2CCCC(O)C2)CC1)N1CCC(N2CCc3ccccc3NC2=O)CC1.
What is the InChIKey of [(2R)-3-(3-bromo-4-hydroxyphenyl)-1-[4-(3-hydroxypiperidin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate?
The InChIKey is LPQYABDKXLYRQM-SLJLDQLWSA-N. The full InChI is InChI=1S/C34H44BrN5O6/c35-28-20-23(7-8-30(28)42)21-31(32(43)37-15-10-25(11-16-37)39-14-3-5-27(41)22-39)46-34(45)38-17-12-26(13-18-38)40-19-9-24-4-1-2-6-29(24)36-33(40)44/h1-2,4,6-8,20,25-27,31,41-42H,3,5,9-19,21-22H2,(H,36,44)/t27?,31-/m1/s1.
What are the key properties of [(2R)-3-(3-bromo-4-hydroxyphenyl)-1-[4-(3-hydroxypiperidin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate?
[(2R)-3-(3-bromo-4-hydroxyphenyl)-1-[4-(3-hydroxypiperidin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate has a molecular weight of 698.66 g/mol, XLogP of 4.20, 6 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R)-3-(3-bromo-4-hydroxyphenyl)-1-[4-(3-hydroxypiperidin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate is sourced from PubChem (CID 143294653), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).